Add Yahoo as a preferred source to see more of our stories on Google. Pharmacist crushing medicine. Compounding pharmacies are facilities that are able to make customized medications. This could be to ...

Key Takeaways Compounded versions of Ozempic and Zepbound are still readily availableFederal regulators had planned to clamp ...

Even after federal shortages of the most popular weight-loss drugs ended, many medical spas are still selling copycat ...

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a ...

Add Yahoo as a preferred source to see more of our stories on Google. Compound drugs are copies of U.S. Food and Drug Administration-approved medications. They are made by licensed pharmacies, but not ...

Arizona-based Strive Compounding Pharmacy has sued Eli Lilly (LLY) and Novo Nordisk (NVO) in a Texas federal court alleging that the drug giants coordinated to stifle competition by hindering access ...

It is easy to differentiate between your local community pharmacy and a large pharmaceutical manufacturer. The pharmacy is viewed as dispensing medications to particular patients with prescriptions ...

The US Food and Drug Administration (FDA) recently warned two online vendors to stop making unapproved versions of semaglutide (marketed as Ozempic for type 2 diabetes; Wegovy for obesity) and ...

Weight-loss treatments like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have been life changing for many individuals seeking to manage their weight. However, shortages and high ...

Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains ...

Discover how compounding pharmacies are transforming healthcare by creating tailor-made medications for patients with unique needs, offering critical alternatives when standard drugs fall short, and ...

The US Food and Drug Administration (FDA) late Friday issued revised versions of two final guidance documents explaining the use of bulk drug substances in compounding and clarifying that the agency ...